Catalyst Wire Dossier Catalyst Wire Dossier

IGT-303

· Ingenia Therapeutics INC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGT-303, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease [Phase 1, Phase 2]

See pricing